Health Insurance News and Research RSS Feed - Health Insurance News and Research

FirstCare Health Plans receives three-year accreditation status from NCQA

FirstCare Health Plans announced today that it has earned three-year Accreditation status from the National Committee for Quality Assurance (NCQA). [More]
Previous joint pain, diabetes and overall health status may predict arthritis pain

Previous joint pain, diabetes and overall health status may predict arthritis pain

Diabetes and previous joint pain, along with a patient's overall physical health status, may predict arthritis pain with nearly 100 percent accuracy, in new research presented today at the 2015 Annual Meeting of the American Academy of Orthopaedic Surgeons (AAOS). [More]
Publicly insured Americans who undergo lung transplantation fare worse than their UK counterparts

Publicly insured Americans who undergo lung transplantation fare worse than their UK counterparts

Publicly insured Americans who undergo lung transplantation for cystic fibrosis fare markedly worse in the long run than both publicly insured patients in the United Kingdom and privately insured Americans, according to the results of a study conducted by researchers from Johns Hopkins in Baltimore and U.K. colleagues working in that nation's government-funded National Health Service. [More]
DaVita HealthCare Partners named Metro Denver's healthiest extra-large employer

DaVita HealthCare Partners named Metro Denver's healthiest extra-large employer

DaVita HealthCare Partners Inc., one of the nation's largest and most innovative health care communities, has been recognized by the Denver Business Journal as Metro Denver's healthiest extra-large employer. This is the fourth consecutive year the company has topped the list because of its commitment to teammate health and wellness. [More]
Genomic Health presents 11 studies demonstrating value of Oncotype DX breast cancer test

Genomic Health presents 11 studies demonstrating value of Oncotype DX breast cancer test

Genomic Health today announced the presentation of 11 studies with the Oncotype DX breast cancer test at the 14th St. Gallen Breast Cancer Conference in Vienna, Austria. Studies presented include results from a real-life observational study in Ireland demonstrating significant reductions in chemotherapy and resulting cost savings when the test is used in early stage breast cancer. [More]

Latinos continue to face problems in accessing high-quality health care

Latinos are the largest ethnic minority group in the United States, and it's expected that by 2050 they will comprise almost 30 percent of the U.S. population. Yet they are also the most underserved by health care and health insurance providers. [More]
Memorial Hermann Sugar Land Hospital wins Texas Award for Performance Excellence

Memorial Hermann Sugar Land Hospital wins Texas Award for Performance Excellence

The Quality Texas Foundation has awarded Memorial Hermann Sugar Land Hospital the Texas Award for Performance Excellence. Memorial Hermann Sugar Land is one of just three organizations in the state to be given this prestigious award recognizing strong dedication to quality and high performance. [More]
Global breast cancer therapeutics market estimated to reach $13.38 billion in 2018

Global breast cancer therapeutics market estimated to reach $13.38 billion in 2018

Despite the availability of approximately 25 drugs for the treatment of breast cancer, the unmet need in the global market is vast. To address this drawback, pharmaceutical companies have established a robust pipeline that currently has about 52 drugs in development. While chemotherapy remains the most important class of drugs for breast cancer treatment, the trend toward targeted drugs is on the rise. [More]
TWi Biotechnology obtains Rare Disease Drug designation in Taiwan for use of AC-203 to treat EBS

TWi Biotechnology obtains Rare Disease Drug designation in Taiwan for use of AC-203 to treat EBS

TWi Pharmaceuticals, Inc. today announced that its fully owned subsidiary, TWi Biotechnology, Inc., has received the designation of Rare Disease Drug by Taiwan FDA for use of AC-203 to treat Epidermolysis Bullosa Simplex (EBS), and is eligible for applying for coverage under National Health Insurance Administration. [More]

OSTAR announces global launch of new patient-centered Vendor Neutral Gateway

OSTAR Healthcare Technology, a Washington State-based Telehealth Solutions company, announced the global launch of its G4 Device Gateway. This revolutionary HIPAA compliant Vendor Neutral Gateway (VNG) provides seamless remote device integration and monitoring for devices such as multi-vendor Glucometers, Vital Signs, Blood Pressure and Weight Scales. [More]
DePaul University experts available to discuss different health care topics

DePaul University experts available to discuss different health care topics

With the fifth anniversary of the presidential signing of the U.S. Affordable Care Act March 23, faculty experts from DePaul University are available to discuss a range of health care topics including the analysis of health care data, community health, patient experience, communication among health care professionals, interprofessional health care education and the role of nurses and physician assistants. [More]
New CPPP report shows that one in four Texas children lives in poverty

New CPPP report shows that one in four Texas children lives in poverty

One in four Texas children lives in poverty, threatening their potential and the state's continued prosperity. According to State of Texas Children 2015, a new Center for Public Policy Priorities (CPPP) report released today, slight improvements in health care and school nutrition don't compensate for inadequate investments in education and child protection. [More]
New healthcare law may threaten federally subsidized coverage for over 2.5 million Americans

New healthcare law may threaten federally subsidized coverage for over 2.5 million Americans

A new study shows that over 2.5 million Americans who have a serious mental health condition in 34 states will become uninsured in 2016, if the Supreme Court rolls back tax credit subsidies that currently make it affordable for those individuals to purchase coverage on federally-run health insurance marketplaces under the Affordable Care Act. [More]
Loss of funding for THC program could disrupt training of medical residents in underserved areas

Loss of funding for THC program could disrupt training of medical residents in underserved areas

The shortage of primary care doctors could worsen if funding for the Teaching Health Centers, a program to train medical residents in underserved areas, is eliminated. Loss of funding - which has already been drastically reduced - could disrupt the training of 550 current medical residents and cut off the pipeline of future primary care residents, says a new report conducted by the Geiger Gibson/RCHN Community Health Foundation Research Collaborative at Milken Institute School of Public Health at the George Washington University. [More]

Some health plans violate federal law requiring equal benefits for mental health care

One-quarter of the health plans being sold on health insurance exchanges set up through the Affordable Care Act offer benefits that appear to violate a federal law requiring equal benefits for general medical and mental health care, according to new research led by the Johns Hopkins Bloomberg School of Public Health. [More]
Nurtur earns Wellness and Health Promotion Accreditation from NCQA for wellness services

Nurtur earns Wellness and Health Promotion Accreditation from NCQA for wellness services

Centene Corporation today announced that Nurtur, its health and wellness company serving employers, health plans and government programs, has received a three-year Wellness and Health Promotion Accreditation renewal from the National Committee for Quality Assurance for its wellness services. [More]
Ninety percent of patients at risk of CHD fail to receive statins

Ninety percent of patients at risk of CHD fail to receive statins

The study, published in Current Medical Research and Opinion, provides the first ever real-world view of the treatment landscape for patients at risk of CHD[1], with a sample of two million patients. But the results paint a bleak picture of prescribing patterns with the majority not being given the potentially life saving drug. [More]
Insurance coverage expansion in Massachusetts increases knee, hip replacement procedures by 4.7%

Insurance coverage expansion in Massachusetts increases knee, hip replacement procedures by 4.7%

Researchers at Boston Medical Center have found that the expansion of insurance coverage in Massachusetts increased the number of elective knee and hip replacement procedures by 4.7 percent, with greater increases among black and Hispanic patients. [More]
UTHealth study explores use of app to help improve health of minority stroke patients

UTHealth study explores use of app to help improve health of minority stroke patients

A clinical trial investigating the use of a physician-monitored app to help first-time minority stroke patients become healthier has begun at The University of Texas Health Science Center at Houston. [More]
Bayer expands patient assistance program for intrauterine devices

Bayer expands patient assistance program for intrauterine devices

Bayer HealthCare Pharmaceuticals Inc. today announced the expansion of its patient assistance program for intrauterine devices (IUD). The ARCH (Access and Resources for Contraceptive Health) program will provide Skyla (levonorgestrel-releasing intrauterine system) 13.5 mg and Mirena (levonorgestrel-releasing intrauterine system) 52 mg to low-income women who meet eligibility criteria. [More]
Advertisement
Advertisement